The US synthetic biology market is anticipated to grow at a CAGR of 31.8% during the forecast period. The synthetic biology market in the US is driven by extensive funding by government officials, increasing number of companies in the field of synthetic biology and technological advancements in the life science sector. Since the beginning of synthetic biology, the US has been conducting synthetic biology research for more than 15 years and has made progress. The US is the largest investor in public research funding and it continues to increase its investment in order to maintain its position at the global level. 

Visit for Global Synthetic Biology Market Report at: https://www.omrglobal.com/industry-reports/synthetic-biology-market-size

Large-scale integrated programs are being funded by the government agencies such as the NSF and DARPA to innovate solutions for sustainable development. Furthermore, the increasing roadmap studies in synthetic biology by the US is promoting R&D in synthetic biology. Road-map studies enable R&D strategies to address key challenges and enable innovative applications. It is anticipated that with the sustainable strategic investment from the US government agencies, synthetic biology will continue to thrive in both basic and applied research in the US.

The US synthetic biology market is segmented on the basis of product, technology, and applications. Based on the product, the market is segmented into enabling products, core products, and enabled products. Core product includes synthetic genes, synthetic cells, synthetic DNA, chassis organisms and Xeno Nucleic Acid (XNA), and are expected to hold a significant share in the market owing to extensive use of core products in R&D. Based on technology, the market is segmented into, and gene synthesis & sequencing, genome engineering, bioinformatics, and others. Based on application, the market is segmented into medical applications, industrial applications, food & agriculture, and environmental applications.

The US synthetic biology industry includes the competitive analysis of various players include Twist Bioscience Corp., Merck KGaA, GenScript Biotech Corp., Thermo Fisher Scientific Inc., Amyris Inc., Codexis Inc, and many others. These players are focusing on agreements along with new product launches for expanding their business. In 2017, Thermo Fisher Scientific, Inc. established a collaboration with AstraZeneca and offered its CRISPR Technology to AstraZeneca’s entire drug discovery platform.

Research Methodology

The market study of the US synthetic biology is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for pharmaceutical companies, drug manufacturers, biotechnology companies, chemical, and biofuel industry, academic and government research institutes, food and agriculture industries, potential investors and venture capitalists, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the company, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. US Synthetic Biology Market Research and Analysis by Product

2. US Synthetic Biology Market Research and Analysis by Technology

3. US Synthetic Biology Market Research and Analysis by Application

The Report Covers

• Comprehensive research methodology of the US synthetic biology market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US synthetic biology market.
• Insights about market determinants which are stimulating the US synthetic biology market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.